Stem cell treatment for ALS gets clinical trial greenlight from FDA – MedCity News
| MedCity News (Reuters) – BrainStorm Cell Therapeutics said the U.S. Food and Drug Administration approved the start of a mid-stage clinical trial of its adult stem cell treatment for patients with amyotrophic lateral sclerosis (ALS). The Phase II trial will be … |
